Market Trends of Global Cell Surface Markers Detection Industry
Flow Cytometry Segment is Expected to Show a Significant Growth Over the Forecast Period.
Flow cytometry is a laser or an impedance-based technology used in cell counting, detecting biomarker, cell sorting, and protein engineering by suspending the cell in a stream of fluid and then passing it through a detection apparatus. It is the ideal tool to identify, characterize, and isolate stem and progenitor cells for research and potential clinical use. The growing adoption of flow cytometry in stem cell research and increasing applications of flow cytometry in clinical research are expected to drive the segment's growth over the forecast period. For instance, according to the National Clinical Trial Registry (NCT), as of April 21, 2021, there were about 320 registered clinical trials across different phases of development related to stem cell therapy in Germany. Thus, the growing research in stem cell therapy is anticipated to drive the demand for flow cytometry over the forecast period.
Additionally, the key strategies implemented by market players, such as launch, approval, partnerships, and collaborations, contribute to the segment's growth. For instance, in July 2021, Becton, Dickinson, and Company launched the reimagined digital marketplace for flow cytometry to provide an enhanced online purchasing experience for users and their procurement teams. The new BD Biosciences marketplace offers a full array of BD's research, clinical, and single-cell multi-omic products, making it an online destination for the most comprehensive flow cytometry users.
Hence, as per the factors mentioned above, the flow cytometry segment will likely grow in the cell surface markers detection market over the forecast period.
North America Dominates the Market and is Expected to Retain its Market Share During the Forecast Period
North America is expected to maintain its overall cell surface markers detection market supremacy throughout the forecast period. Rapidly growing applications in disease diagnostics, the presence of well-established research institutions, and the biotech industry are the primary factors behind the significant market share. The increase in government initiatives toward R&D is contributing to market growth. For instance, as per a 2021 update by the University of North Dakota, the UND Center of Biomedical Research Excellence (CoBRE) in Host-Pathogen interactions (HPI) learned that it will continue to receive National Institutes of Health (NIH) funding through the project's Phase 2. The renewal amount was more than USD 10.7 million to UND for the multi-year project for obtaining a better understanding of the host responses to viral, bacterial, and parasitic infections that cause acute and chronic inflammatory disorders. The Center will also enhance the innovative research capabilities of the School of Medicine & Health Sciences (SMHS) and UND by supporting three existing Phase 1 Core facilities, including flow cytometry. Such developments are anticipated to contribute to the growth of the market in the region.
Additionally, the presence of major market players and key strategies implemented by them such as partnerships and collaborations are also contributing to the market growth. For instance, in September 2021, PHC Corporation of North America and Screen Holdings Co., Ltd partnered to market the Screen Cell imager series of cell imaging systems in North America. Similarly, in August 2021, Becton, Dickinson and Company launched a new benchtop cell analyzer, BD FACSymphony A1 Cell Analyzer. The fluorescence-activated cell analyzer is expected to equip laboratories of all sizes with sophisticated flow cytometry capabilities. Such development is expected to drive the growth of the market over the forecast period.
